A rare trigger for macrophage activation syndrome

descriptionPublicationkeyboard_double_arrow_right Article 16 Oct 2009 English Publisher:Springer Science and Business Media LLCJournal:Rheumatology International, volume 31, pages 405-407 (issn: 0172-8172, eissn: 1437-160X,

Copyright policy )

Authors: Shikhar, Agarwal; Jayavani, Moodley; Gati, Ajani Goel; Karl S, Theil; Syed S, Mahmood; Richard S, Lang;

doi: 10.1007/s00296-009-1204-0

pmid: 19834709

A rare trigger for macrophage activation syndrome

- Summary
- Subjects
- Metrics

Abstract

Macrophage activation syndrome (MAS) is a disorder characterized by increased activation of mononuclear cells leading to phagocytosis of blood cell precursors in the bone marrow. We describe a case of MAS triggered by disseminated histoplasmosis occurring in a patient with Still's disease on long-term treatment with adalimumab.

Related Organizations

Cleveland Clinic
United States
Case Western Reserve University
United States

Keywords

Young Adult, Phagocytosis, Antirheumatic Agents, Macrophage Activation Syndrome, Adalimumab, Antibodies, Monoclonal, Humans, Antibodies, Monoclonal, Humanized, Histoplasmosis, Still's Disease, Adult-Onset

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	31
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%